SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001532176-17-000034
Filing Date
2017-11-08
Accepted
2017-11-08 07:54:13
Documents
65
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q regn-093017x10q.htm 10-Q 1940879
2 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) regn-ex_311x09302017x10q.htm EX-31.1 16767
3 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) regn-ex_312x09302017x10q.htm EX-31.2 16763
4 CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 regn-ex_32x09302017x10q.htm EX-32 8090
  Complete submission text file 0001532176-17-000034.txt   7038567

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT regn-20170930.xml EX-101.INS 1387376
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT regn-20170930.xsd EX-101.SCH 43040
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT regn-20170930_cal.xml EX-101.CAL 75637
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT regn-20170930_def.xml EX-101.DEF 328747
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT regn-20170930_lab.xml EX-101.LAB 569195
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT regn-20170930_pre.xml EX-101.PRE 374013
Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9143477000
REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19034 | Film No.: 171185117
SIC: 2834 Pharmaceutical Preparations